학술논문

Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer
Document Type
article
Source
European Urology. 76(1)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Oncology and Carcinogenesis
Prostate Cancer
Aging
Urologic Diseases
Cancer
Biomedical Imaging
4.1 Discovery and preclinical testing of markers and technologies
Detection
screening and diagnosis
Aged
Gene Dosage
Gene Expression Profiling
Genome
Humans
Male
Middle Aged
Multiparametric Magnetic Resonance Imaging
Prostatic Neoplasms
RNA
Long Noncoding
RNA
Messenger
RNA
Small Nuclear
Transcriptome
Tumor Burden
Tumor Microenvironment
Prostate cancer
Multiparametric magnetic resonance imaging visibility
Radiogenomics
Nimbosus
Transcriptomics
Urology & Nephrology
Clinical sciences
Language
Abstract
Multiparametric magnetic resonance imaging (mpMRI) has transformed the management of localized prostate cancer by improving identification of clinically significant disease at diagnosis. Approximately 20% of primary prostate tumors are invisible to mpMRI, and we hypothesize that this invisibility reflects fundamental molecular properties of the tumor. We therefore profiled the genomes and transcriptomes of 40 International Society of Urological Pathology grade 2 tumors: 20 mpMRI-invisible (Prostate Imaging-Reporting and Data System [PI-RADS] v2